ARG1 and cancer: This knockdown in receptor activation translated to dose‐dependent decrease in expression of arginase‐1 (Arg‐1), an anti‐inflammatory cytokine that mediates tumor progression and metastasis and correlates with cancer grade and prognosis (Figure 4b).27